The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for the treatment of cardiogenic shock (CS) may result in left ventricle overload and distension. Percutaneous microaxial flow pump Impella in addition to VA-ECMO (ECPELLA) is an emerging option to overcome these collateral effects. Aim of this study is to assess whether the addition of Impella to VA-ECMO is an effective and safe unloading strategy.
Cappannoli, L., Galli, M., Zito, A., Restivo, A., Princi, G., Laborante, R., Vergallo, R., Romagnoli, E., Leone, A. M., Aurigemma, C., Massetti, M., Sanna, T., Trani, C., Burzotta, F., Savarese, G., Crea, F., D'Amario, D., Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis, <<EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES (ONLINE)>>, 2022; (12 nov): N/A-N/A. [doi:10.1093/ehjqcco/qcac076] [https://hdl.handle.net/10807/221865]
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis
Cappannoli, Luigi;Galli, Mattia;Zito, Andrea;Restivo, Attilio;Princi, Giuseppe;Laborante, Renzo;Vergallo, Rocco;Leone, Antonio Maria;Aurigemma, Cristina;Massetti, Massimo;Sanna, Tommaso;Trani, Carlo;Burzotta, Francesco;Crea, Filippo;D'Amario, Domenico
2022
Abstract
The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for the treatment of cardiogenic shock (CS) may result in left ventricle overload and distension. Percutaneous microaxial flow pump Impella in addition to VA-ECMO (ECPELLA) is an emerging option to overcome these collateral effects. Aim of this study is to assess whether the addition of Impella to VA-ECMO is an effective and safe unloading strategy.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
